May 18, 2021
In episode 27, Dr. Grant Stevens takes us on a tour of a different side of the aesthetics business as he interviews the investment banking team from Jefferies Financial Group that recently took The HydraFacial Company public in a SPAC (Special Purpose Acquisition Company) merger deal with former Allergan CEO Brent Saunders.
Tune in to hear insights from Michael Robinson (Global Head of Medical Device Investment Banking, Jefferies) and Sasha Radic (Senior Vice President, Jefferies) and get a behind-the-scenes look at the potential that these financial experts see for the aesthetic medicine sector going forward.